Out-licensing

We are eager to out-license our Nuntius biotechnology to mRNA players for the development of mRNA vaccines and therapies.

Last news

our-mrna-platform-page

Messenger Biopharma in Lyonbiopole’s newsletter

posted December 22, 2016

  Please click on this ...Read More

Recent Search Keywords